Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takashi Yamanaka
Observed name:
T. Yamanaka
Institution:
Kanagawa Cancer Center
Observed institution:
Kanagawa Cancer Center
ORCID:
0009-0004-0081-4263
Observed ORCID:
0009-0004-0081-4263
OpenAlex ID:
A5126526074
AdipoR1–AMPK axis suppresses breast cancer across molecular subtypes via multimodal cell death pathways, including ferroptosis and apoptosis
2026
·
Shinya Sato
, Takashi Yamanaka
, et al.
·
Cell Death and Disease
·
1
PDF
Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study
2026
·
Norikazu Masuda
, Hiroyuki Yasojima
, et al.
·
Breast Cancer Research and Treatment
·
1
PDF
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial
2026
·
Takashi Yamanaka
, Joohyuk Sohn
, et al.
·
Breast Cancer
PDF
Online peer support for breast cancer survivors: A decentralized multicenter non-blinded parallel-group pilot randomized controlled trial (HOPE-BC study).
2026
·
Yoshie Hasegawa
, Ken Kurisu
, et al.
·
Journal of Clinical Oncology
Clinicopathological predictors of distant recurrence in breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy
2026
·
Asako Yamamoto
, Mariko Asaoka
, et al.
·
European Journal of Surgical Oncology
Abstract PS4-01-22: The Utility of MT1-MMP in Predicting Treatment Efficacy with HER2-positive advanced or metastatic breast cancer: JBCRG-M06/EMERALD trial TR
2026
·
M. Yasukawa
, S. Sato
, et al.
·
Clinical Cancer Research
Abstract PD13-11: Interim analysis results for the effectiveness and safety of trastuzumab deruxtecan in patients with HER2-low breast cancer and brain metastases: The HALLOW study
2026
·
N. Niikura
, T. Yamanaka
, et al.
·
Clinical Cancer Research
Abstract PS2-09-07: Ultra-sensitive Molecular Residual Disease Detection in Breast Cancer Using Whole-Genome Sequencing-Based Personalized ctDNA Panels: Preliminary Results from the MONSTAR-SCREEN-3 Project
2026
·
Y. Naito
, M. Nishimura
, et al.
·
Clinical Cancer Research
Abstract PS5-03-26: A Prospective Observational Study of Atezolizumab plus Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer: First Analysis of JBCRG-C08/ATTRIBUTE
2026
·
T. Shimoi
, N. Shibata
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
9
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type